4-(3-(((2-amino-5-(2-(1-methylpiperidin-4-yl)thiazol-5-yl)pyridin-3-yl)oxy)methyl)phenyl)-2-methylbut-3-yn-2-ol

95%

Reagent Code: #133450
fingerprint
CAS Number 2380300-79-6

science Other reagents with same CAS 2380300-79-6

blur_circular Chemical Specifications

scatter_plot Molecular Information
Weight 462.607 g/mol
Formula C₂₆H₃₀N₄O₂S
thermostat Physical Properties
Boiling Point 647.3±55.0 °C(Predicted)
inventory_2 Storage & Handling
Density 1.29±0.1 g/cm3(Predicted)
Storage 2-8°C

description Product Description

Used in pharmaceutical research as a potent and selective inhibitor of Janus kinase 3 (JAK3), showing potential for treating autoimmune diseases such as rheumatoid arthritis and psoriasis. Its structure enables high selectivity over other JAK family members, reducing off-target effects. Investigated for modulating immune responses without broad immunosuppression. Also explored in oncology for JAK-STAT pathway-driven cancers. Suitable for in vitro and in vivo studies due to metabolic stability and cell permeability.

shopping_cart Available Sizes & Pricing

Size Availability Unit Price Quantity
inventory 25mg
10-20 days ฿96,000.00
inventory 100mg
10-20 days ฿192,000.00

Cart

No products

Subtotal: 0.00
Total 0.00 THB
4-(3-(((2-amino-5-(2-(1-methylpiperidin-4-yl)thiazol-5-yl)pyridin-3-yl)oxy)methyl)phenyl)-2-methylbut-3-yn-2-ol
No image available

Used in pharmaceutical research as a potent and selective inhibitor of Janus kinase 3 (JAK3), showing potential for treating autoimmune diseases such as rheumatoid arthritis and psoriasis. Its structure enables high selectivity over other JAK family members, reducing off-target effects. Investigated for modulating immune responses without broad immunosuppression. Also explored in oncology for JAK-STAT pathway-driven cancers. Suitable for in vitro and in vivo studies due to metabolic stability and cell pe

Used in pharmaceutical research as a potent and selective inhibitor of Janus kinase 3 (JAK3), showing potential for treating autoimmune diseases such as rheumatoid arthritis and psoriasis. Its structure enables high selectivity over other JAK family members, reducing off-target effects. Investigated for modulating immune responses without broad immunosuppression. Also explored in oncology for JAK-STAT pathway-driven cancers. Suitable for in vitro and in vivo studies due to metabolic stability and cell permeability.

Mechanism -
Appearance -
Longevity -
Strength -
Storage -
Shelf Life -
Allergen(s) -
Dosage (Range) -
Dosage (Per Day) -
Mix Method -
Heat Resistance -
Stable in pH range -
Solubility -
Product Types -
INCI -

Purchase History for

Loading purchase history...